Trials / Completed
CompletedNCT04472039
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Vienna Institute for Research in Ocular Surgery · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes.
Detailed description
Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. Nevertheless, there are about 10% of patients having intraretinal cystoid changes after surgery with potential for disturbance of visual acuity. The aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | optical coherence tomography (OCT) | OCT visualizes the retinal layers by backreflection of light |
Timeline
- Start date
- 2020-06-30
- Primary completion
- 2020-09-28
- Completion
- 2020-09-28
- First posted
- 2020-07-15
- Last updated
- 2020-09-29
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04472039. Inclusion in this directory is not an endorsement.